degenerative disc disease
-
Financial
Degenerative Disc Disease Market Size to Grow by USD 1.03 billion, Launch of Innovative Products to be a Key Trend – Technavio
NEW YORK, Sept. 27, 2022 /PRNewswire/ — One of the key trends in the degenerative disc disease market is the launch of innovative…
Read More » -
Spine
DiscGenics Announces Presentation of Positive Interim Clinical Data from Phase 1/2 Study of Cell Therapy for Degenerative Disc Disease
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and…
Read More » -
Spine
Aurora Spine Plans A Major Multicenter Study of its ZIP™ Interspinous Fixation Device for Relief of Back Pain
CARLSBAD, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer…
Read More » -
Spine
CoreLink Introduces Oro Lateral Plate System Designed for Optimum Versatility to Treat Patients Suffering From Spinal Conditions
September 18, 2019 ST. LOUIS–(BUSINESS WIRE)–CoreLink, LLC, a leading designer and manufacturer of spinal implant systems, today announced the introduction…
Read More » -
Spine
Nocimed Announces First Commercial Clients for New Non-Invasive Spinal Pain Assessment Tool In North America and Europe
Nocimed, the leader in the adjunct diagnosis of degenerative disc disease (DDD) pain, has announced that NociScan, a non-invasive test…
Read More » -
Biologics
Kuros Biosciences Announces U.S. FDA approval of IND Application to Initiate Fibrin-PTH Phase 2a Clinical Trial in Spinal Fusion
Kuros to conduct Phase 2a trial in spinal fusion, comparing Fibrin-PTH to autograftPrimary endpoint is radiographic interbody fusion at 12 months SCHLIEREN…
Read More » -
Spine
Nocimed Announces Publication of Using Magnetic Resonance Spectroscopy to Identify Painful Lumbar Discs in the European Spine Journal
by Josh Sandberg, August 23, 2019 Nocimed, the leader in the adjunct diagnosis of degenerative disc disease (DDD) pain, has…
Read More » -
Biologics
SpinalCyte, LLC Announces New International Patent
January 08, 2019 SAN FRANCISCO–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using…
Read More » -
Spine
SpinalCyte Announces Positive 12 Month Pain Data From Phase 1/Phase 2 Clinical Trial for Degenerative Disc Disease
October 25, 2018 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using…
Read More » -
Biologics
SpinalCyte Announces Publication of Fibroblast Cell Therapy Review in the Journal of Translational Medicine
July 31, 2018 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human…
Read More » -
Spine
Spineology U.S. Clinical Trial for Interbody Fusion
April 12, 2018 ST. PAUL, Minn.–(BUSINESS WIRE)–Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce that John…
Read More » -
Biologics
SpinalCyte Announces MRI Evidence of Disc Regeneration Following Phase 1/Phase 2 Clinical Trial of CybroCell™ Dermal Fibroblasts
April 03, 2018 HOUSTON–(BUSINESS WIRE)–MRI analysis of patients who received intradiscal injections of human dermal fibroblasts (HDFs) shows significant improvement…
Read More » -
Spine
SeaSpine Launches Cambria(TM) NanoMetalene(R) Interbody Device
VISTA, Calif., Oct 16, 2015 (GLOBE NEWSWIRE via COMTEX) — SeaSpine Holdings Corporation SPNE, -3.72% a global medical technology company focused on surgical…
Read More » -
Recon
Stem Cell Study for Back Pain Begins
By Pat Anson Enrollment has begun in a clinical study of an experimental stem cell therapy that could – if…
Read More » -
Hospitals
B. Braun’s Aesculap wins FDA nod for lumbar disc
By Fink Densford B. Braun Medical subsidiary Aesculap said today that it won FDA approval for its ActivL artificial disc indicated for the…
Read More »